CNBC
US · 45 mins ago
The startup using AI to help rare disease families develop custom treatments
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
Do you trust CNBC?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!